Problem being addressed
Women in developing nations often do not have access to contraceptives, and in the case that they do, may find it difficult to adhere to tedious guidelines on a regular basis. Essentially, there is a need for easy-to-use, cost-effective contraceptives that do not require regular maintenance or effort.
Detailed description of the solution
This innovative drug delivery system is a subcutaneous biosynthetic bone-like material made of calcium minerals that, once implanted, can deliver contraceptives at regular intervals in a sustained manner for several months.
Designed by
- Designed by: This device is currently being developed by Gérrard Poinern of Murdoch University in Australia.
- Manufacturer location: Murdoch University in Perth, Australia
When and where it was tested/implemented
A research group is currently developing the technology to be feasible, and if successful, will collaborate with a drug company to begin human trials.
Funding Source
This device received funding from the Grand Challenges Exploration Grant from the Bill & Melinda Gates Foundation.
References
Other internally generated reports
Murdoch receives $100,000 to develop a contraceptive for third world. (2010, November 10). Murdoch University. Retrieved February 5, 2013. Link available here.
Externally generated reports
Grand Challenges Explorations: Round 5 Winners Highlights. (n.d.). Bill & Melinda Gates Foundation. Retrieved February 5, 2013. Link available here.